These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 21524402)

  • 1. [West Nile virus. II. Immunopathophysiology in humans].
    Lanteri MC; Diamond MS; Norris PJ; Busch MP
    Med Sci (Paris); 2011 Apr; 27(4):382-6. PubMed ID: 21524402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice.
    Ben-Nathan D; Lustig S; Tam G; Robinzon S; Segal S; Rager-Zisman B
    J Infect Dis; 2003 Jul; 188(1):5-12. PubMed ID: 12825165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. West Nile virus: should pediatricians care?
    Smith JC; Mailman T; MacDonald NE
    J Infect; 2014 Nov; 69 Suppl 1():S70-6. PubMed ID: 25138381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ribavirin inhibits West Nile virus replication and cytopathic effect in neural cells.
    Jordan I; Briese T; Fischer N; Lau JY; Lipkin WI
    J Infect Dis; 2000 Oct; 182(4):1214-7. PubMed ID: 10979920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy, duration, and onset of immunogenicity of a West Nile virus vaccine, live Flavivirus chimera, in horses with a clinical disease challenge model.
    Long MT; Gibbs EP; Mellencamp MW; Bowen RA; Seino KK; Zhang S; Beachboard SE; Humphrey PP
    Equine Vet J; 2007 Nov; 39(6):491-7. PubMed ID: 18065305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Infections caused by West Nile virus].
    Hermanowska-Szpakowicz T; Grygorczuk S; Kondrusik M; Zajkowska J; Pancewicz S
    Przegl Epidemiol; 2006; 60(1):93-8. PubMed ID: 16758745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic systems of West Nile virus and their potential applications.
    Shi PY
    Curr Opin Investig Drugs; 2003 Aug; 4(8):959-65. PubMed ID: 14508880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping and analysis of West Nile virus-specific monoclonal antibodies: prospects for vaccine development.
    Throsby M; Ter Meulen J; Geuijen C; Goudsmit J; de Kruif J
    Expert Rev Vaccines; 2007 Apr; 6(2):183-91. PubMed ID: 17408368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse.
    El Garch H; Minke JM; Rehder J; Richard S; Edlund Toulemonde C; Dinic S; Andreoni C; Audonnet JC; Nordgren R; Juillard V
    Vet Immunol Immunopathol; 2008 Jun; 123(3-4):230-9. PubMed ID: 18372050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The continuing spread of West Nile virus in the western hemisphere.
    Gubler DJ
    Clin Infect Dis; 2007 Oct; 45(8):1039-46. PubMed ID: 17879923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunity.
    McDonald WF; Huleatt JW; Foellmer HG; Hewitt D; Tang J; Desai P; Price A; Jacobs A; Takahashi VN; Huang Y; Nakaar V; Alexopoulou L; Fikrig E; Powell TJ
    J Infect Dis; 2007 Jun; 195(11):1607-17. PubMed ID: 17471430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined treatment of adenosine nucleoside inhibitor NITD008 and histone deacetylase inhibitor vorinostat represents an immunotherapy strategy to ameliorate West Nile virus infection.
    Nelson J; Roe K; Orillo B; Shi PY; Verma S
    Antiviral Res; 2015 Oct; 122():39-45. PubMed ID: 26225754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptation of West Nile virus replicons to cells in culture and use of replicon-bearing cells to probe antiviral action.
    Rossi SL; Zhao Q; O'Donnell VK; Mason PW
    Virology; 2005 Jan; 331(2):457-70. PubMed ID: 15629788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-year sequelae in patients with West Nile Virus encephalitis and meningitis in Louisiana.
    Ou AC; Ratard RC
    J La State Med Soc; 2005; 157(1):42-6. PubMed ID: 15887668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice.
    Liu WJ; Wang XJ; Clark DC; Lobigs M; Hall RA; Khromykh AA
    J Virol; 2006 Mar; 80(5):2396-404. PubMed ID: 16474146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manifestations of West Nile neuroinvasive disease.
    Sejvar JJ; Marfin AA
    Rev Med Virol; 2006; 16(4):209-24. PubMed ID: 16906589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Investigation of West Nile virus in central nervous system infections of unknown etiology in Ankara, Turkey].
    Ergünay K; Aydoğan S; Menemenlioğlu D; Sener B; Lederer S; Steinhagen K; Hasçelik G; Pinar A; Ozkul A; Us D
    Mikrobiyol Bul; 2010 Apr; 44(2):255-62. PubMed ID: 20549960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The outbreak of West Nile virus infection in the New York City area in 1999.
    Nash D; Mostashari F; Fine A; Miller J; O'Leary D; Murray K; Huang A; Rosenberg A; Greenberg A; Sherman M; Wong S; Layton M;
    N Engl J Med; 2001 Jun; 344(24):1807-14. PubMed ID: 11407341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case-control study of factors associated with development of clinical disease due to West Nile virus, Saskatchewan 2003.
    Epp T; Waldner C; Townsend HG
    Equine Vet J; 2007 Nov; 39(6):498-503. PubMed ID: 18065306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. West Nile virus and kidney disease.
    Barzon L; Pacenti M; Palù G
    Expert Rev Anti Infect Ther; 2013 May; 11(5):479-87. PubMed ID: 23627854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.